Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
about
SSEA-4 and YKL-40 positive progenitor subtypes in the subventricular zone of developing human neocortexSmoking, inflammation and small cell lung cancer: recent developments.hYKL-40 cancer biomarker electroanalysis in serum samples and model cell lysates: capacitive immunosensing compared with enzyme label immunosorbent assays (ELISA).Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis.Commentary: IL-4 and IL-13 receptors and signalingHow to target small cell lung cancer.Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial.YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
P2860
Q37308951-B5FCEF54-5660-4D1C-9FD8-78EB398E9023Q38569752-D954A3DD-D3BF-47AD-9BEF-5183DA4CF449Q38720400-7DA06A85-C7B8-4E0C-9C67-07AC43B46CAEQ38811271-6B0FB161-6DE3-4956-AD77-5877D9D5ED6BQ41818218-36BE1C07-7C5F-4213-85B6-9D4E14E00874Q43242537-EB409302-0D0A-44AB-BBCA-9D5A88CB691AQ50293199-0695F059-9091-4ABF-99BA-5DA5297064E9Q58742056-DED1DC31-52CA-4F5D-9C8A-F00A99C58780
P2860
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@ast
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@en
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@nl
type
label
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@ast
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@en
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@nl
prefLabel
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@ast
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@en
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@nl
P2860
P356
P1476
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
@en
P2093
Adília Hormigo
Fabio M. Iwamoto
P2860
P356
10.3389/FONC.2014.00090
P407
P577
2014-01-01T00:00:00Z